$12.35-0.15|(-1.20%)
52W H: 17.5852W L: 5.37Beta: 1.69

About Ginkgo Bioworks Holdings Inc

Frequently Asked Questions

What is the 52-week range for DNA?

The 52-week high is $17.58 and the 52-week low is $5.37.

What is the P/E ratio for DNA?

The P/E ratio data is currently unavailable.

What is the dividend yield for DNA?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -60.21%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -259.96%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 0.99.

Analyst Recommendation Trends

Wall Street analyst consensus for DNA over the last few months:

2026-09-01
Buy: 0
S.Buy: 0
Hold: 3
Sell: 5
2026-08-01
Buy: 1
S.Buy: 0
Hold: 2
Sell: 5
2026-07-01
Buy: 1
S.Buy: 0
Hold: 2
Sell: 5
2026-06-01
Buy: 1
S.Buy: 0
Hold: 2
Sell: 5

Latest DNA News

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know

In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $12.5, denoting a -2.57% move from the preceding trading day.

Yahoo10/1/2026

Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

BOSTON, September 29, 2026--Ginkgo Datapoints and Apheris welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

Yahoo9/29/2026

What Needs To Be True To Buy Twist Bioscience Stock Now?

A $10,000 holding in Twist Bioscience (TWST) a year ago is worth about $66,600 today. The same sum in the S&P 500 would be worth about $11,700. The company sells made-to-order DNA to drug makers and research labs. Its sales grow fast, but it still loses money. The price now counts on that growth lasting and the losses ending. How much has to go right for that price to hold.

Yahoo9/25/2026

Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday

Nasdaq fell 150+ points, while Everpure jumped 14% after unveiling growth plans and a FY2028 outlook; other stocks also gained.

Benzinga9/24/2026

Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.58, marking a -8.43% move from the previous day.

Yahoo9/23/2026

Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?

Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Yahoo9/18/2026

Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $7.06, signifying a +1% move from its prior day's close.

Yahoo9/16/2026

Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data

BOSTON, September 16, 2026--Ginkgo Bioworks (NYSE: DNA) today announced that its Ginkgo Datapoints offering has entered into a new agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab supports biotech innovation by enabling participating companies to access AI/ML drug discovery models trained on decades of Lilly's proprietary research data.

Yahoo9/16/2026

Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines

BOSTON, September 10, 2026--Ginkgo Bioworks (NYSE: DNA) today announced that it has been awarded a subcontract for up to $17.5M under the Advanced Research Projects Agency for Health’s (ARPA-H) Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. Ginkgo will serve as a subcontractor to prime contractor Waterfall Scientific, Inc. on ESCALATOR (Engineering a Small-scale, Continuous-flow manufacturing Apparatus to Launch A Transformational Overhaul for RNA medicines), a m

Yahoo9/10/2026

BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target

BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintains $5 price target.

Benzinga9/4/2026

Related Stocks (Peers)

Companies operating in similar sectors to DNA:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-15HENRY CHRISTIAN O-5,000$7.081$35,405
2026-08-24Coen Steven P.-330$6.977$2,302
2026-08-21Coen Steven P.-156--
2026-08-21Coen Steven P.-587--
2026-08-21Coen Steven P.+156--
2026-08-21Coen Steven P.+587--
2026-07-28Canton Barry+127,423--
2026-07-28Canton Barry+39,038--
2026-07-28Canton Barry+117,135--
2026-07-28Canton Barry+35,736--
2026-07-28Shetty Reshma P.+117,135--
2026-07-28Shetty Reshma P.+35,736--
2026-07-28Shetty Reshma P.+127,423--
2026-07-28Shetty Reshma P.+39,038--
2026-07-28Kelly Jason R+309,467--
2026-07-28Kelly Jason R+74,258--
2026-07-17Coen Steven P.-752$7.903$5,943
2026-07-16Coen Steven P.-312--
2026-07-16Coen Steven P.-1,174--
2026-07-16Coen Steven P.+312--
2026-07-16Coen Steven P.+1,174--
2026-06-11Fubini Ross+25,000--
2026-06-11Kosuri Sri+25,000--
2026-06-11HENRY CHRISTIAN O+25,000--
2026-06-11SLOAN HARRY+25,000--
2026-05-22Coen Steven P.-307$8.334$2,559
2026-05-21Coen Steven P.-156--
2026-05-21Coen Steven P.-587--
2026-05-21Coen Steven P.+156--
2026-05-21Coen Steven P.+587--
2026-04-17Coen Steven P.-324$7.952$2,576
2026-04-16Coen Steven P.-156--
2026-04-16Coen Steven P.-587--
2026-04-16Coen Steven P.+156--
2026-04-16Coen Steven P.+587--
2026-04-13Coen Steven P.-33,171$6.414$212,759
2026-04-10Coen Steven P.-45,553--
2026-04-10Coen Steven P.-28,368--
2026-04-10Coen Steven P.+45,553--
2026-04-10Coen Steven P.+28,368--
2026-04-10Canton Barry-124,727$6.434$802,494
2026-04-10Shetty Reshma P.-124,727$6.434$802,494
2026-04-09Canton Barry-251,786--
2026-04-09Canton Barry+251,786--
2026-04-09Shetty Reshma P.-251,786--
2026-04-09Shetty Reshma P.+251,786--
2026-04-09Shetty Reshma P.-13,116$6.397$83,903
2026-04-09Canton Barry-13,116$6.397$83,903
2026-04-09Kelly Jason R-109,767$6.397$702,179
2026-04-08Shetty Reshma P.-27,738--
2026-04-08Shetty Reshma P.-13,155$6.93$91,164
2026-04-08Shetty Reshma P.+27,738--
2026-04-08Canton Barry-27,738--
2026-04-08Canton Barry-13,155$6.93$91,164
2026-04-08Canton Barry+27,738--
2026-04-08Kelly Jason R-212,949--
2026-04-08Kelly Jason R-97,015$6.93$672,314
2026-04-08Kelly Jason R+212,949--
2026-04-07Shetty Reshma P.-27,738--
2026-04-07Shetty Reshma P.+27,738--
2026-04-07Canton Barry-27,738--
2026-04-07Canton Barry+27,738--
2026-04-07Kelly Jason R-212,949--
2026-04-07Kelly Jason R+212,949--
2026-03-16Coen Steven P.-708$6.735$4,768
2026-03-13Coen Steven P.-312--
2026-03-13Coen Steven P.-1,174--
2026-03-13Coen Steven P.+312--
2026-03-13Coen Steven P.+1,174--
2026-01-20Coen Steven P.-972$8.917$8,667
2026-01-16Coen Steven P.-1,062--
2026-01-16Coen Steven P.-156--
2026-01-16Coen Steven P.-587--
2026-01-16Coen Steven P.+1,062--
2026-01-16Coen Steven P.+156--
2026-01-16Coen Steven P.+587--
2025-12-15Coen Steven P.-736$8.886$6,540
2025-12-12Coen Steven P.-312--
2025-12-12Coen Steven P.-1,174--
2025-12-12Coen Steven P.+312--
2025-12-12Coen Steven P.+1,174--
2025-10-17Coen Steven P.-1,312$13.649$17,907
2025-10-16Coen Steven P.-1,061--
2025-10-16Coen Steven P.-312--
2025-10-16Coen Steven P.-1,174--
2025-10-16Coen Steven P.+1,061--
2025-10-16Coen Steven P.+312--
2025-10-16Coen Steven P.+1,174--